Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Missing the bull's eye.

Molly E Gilbert1, Peter J Savino

  • 1Neuro-ophthalmology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Survey of Ophthalmology
|June 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-Arteritic Anterior Ischaemic Optic Neuropathy and Its Masquerades: A Comprehensive Diagnostic Review.

Clinical & experimental ophthalmology·2026
Same author

Unilateral papilledema: illustrative case.

Journal of neurosurgery. Case lessons·2024
Same author

Looking beyond blurred margins.

Survey of ophthalmology·2024
Same author

Temporal patterns of visual recovery following pituitary tumor resection: A prospective cohort study.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2021
Same author

Case report <sup>68</sup>Ga-DOTATATE of optic nerve sheath meningioma.

American journal of ophthalmology case reports·2021
Same author

Prognostic Utility of Optical Coherence Tomography for Long-Term Visual Recovery Following Pituitary Tumor Surgery.

American journal of ophthalmology·2020
Same journal

Efficacy and safety of different intraocular therapies for non-infectious uveitis: A network meta-analysis.

Survey of ophthalmology·2026
Same journal

Macular telangiectasia masqueraders.

Survey of ophthalmology·2026
Same journal

Utilization of anterior segment optical coherence tomography in childhood glaucoma: A systematic review.

Survey of ophthalmology·2026
Same journal

Peripapillary pachychoroid syndrome: Clinical and imaging features, diagnostic differentiation and therapeutic strategies.

Survey of ophthalmology·2026
Same journal

Prognostic factors and postoperative outcomes in pediatric cataract patients: A systematic review and meta-analysis.

Survey of ophthalmology·2026
Same journal

Predicting the progression of proliferative diabetic retinopathy: Pathophysiology, imaging phenotypes, and determinants of disease persistence despite therapy.

Survey of ophthalmology·2026
See all related articles

Hydroxychloroquine retinopathy screening may be improved. Multifocal electroretinography (mfERG) can detect early macular dysfunction in patients taking hydroxychloroquine, potentially before standard screening methods.

Area of Science:

  • Ophthalmology
  • Retinal Imaging
  • Pharmacovigilance

Background:

  • Hydroxychloroquine (HCQ) is widely prescribed for autoimmune conditions.
  • Long-term HCQ use can lead to retinal toxicity, specifically hydroxychloroquine retinopathy.
  • Current screening guidelines aim to detect this toxicity early.

Observation:

  • A patient with a history of HCQ use presented for routine eye examination.
  • Standard clinical examinations, following American Academy of Ophthalmology guidelines, revealed no abnormalities.
  • A multifocal electroretinogram (mfERG) was performed to evaluate macular function.

Findings:

  • Multifocal electroretinography (mfERG) demonstrated the ability to detect subclinical macular dysfunction.
  • This dysfunction was present in a patient with HCQ use despite normal clinical findings.

Related Experiment Videos

  • mfERG may identify early signs of hydroxychloroquine retinopathy.

    • Implications:

    • Multifocal electroretinography (mfERG) could serve as an earlier screening tool for hydroxychloroquine retinopathy.
    • Implementing mfERG may allow for earlier intervention and potentially prevent vision loss.
    • This highlights the importance of advanced electrophysiological testing in monitoring patients on long-term HCQ therapy.